In-vitro and in-silico analysis of the effect of fluconazole, an antifungal drug, on DNA

Sumeyye Zarf, Ibrahim Arman


Fluconazole is an important antifungal drug used worldwide for the treatment of peritonitis and cryptococcal meningitis, urinary tract infections, esophageal tract infections and vaginal candidiasis. In this research, pUC19 plasmid DNA was treated with different concentrations of fluconazole in the presence of ascorbic acid, H2O2, iron, iron plus H2O2, copper and copper plus ascorbic acid, followed by agarose gel electrophoresis. Fluconazole-DNA interactions were investigated by UV-Vis spectrophotometeric titration and in-silico methods. Even in the presence of an oxidative agent and a reducing agent, the double stranded DNA was not broken with higher concentrations of fluconazole than those found in human plasma. Fluconazole concentrations ≥ 88 μM could protect 46 µM of DNA against radical hydroxyl produced by the reaction between 1.5 mM of FeSO4 and 6 mM of H2O2 while the drug concentrations ≤ 44 μM could not provide the protection. In addition, the drug could not protect DNA against the ROS originated from the reaction between copper and ascorbic acid. The binding constant of fluconazole-DNA in UV-Vis spectrophotometry analysis and docking analysis was estimated as 1.087×103 and 6.22×105 M-1, respectively.


DNA; fluconazole; antifungal; docking; interactions

Full Text:

PDF (1,322 kB)


L. Peyton, S. Gallagher, M. Hashemzadeh, Drugs Today (Barc) 51 (2015) 705 (

S. Revankar, J. Fu, M. Rinaldi, S. Kelly, D. Kelly, D. Lamb, S. Keller, B. L. Wickes, Biochem. Biophys. Res. Commun. 324 (2004) 719 (

J. D. Davis, S.-Y. Lin, World J. Clin. Oncol. 2 (2011) 329 (

K. Gurova, Future Oncol. 5 (2009)1685 ( )

B. Ç. Toptanci, G. Kizil, M. Kızil, Middle East J. Sci. 2 (2016) 33 (

C. Bertoncini, R. Meneghini, F. Galembeck, M. Calió, A. Carbonel, J. Cancer Sci. Ther. 8 (2016) 213 (

G. J. Brewer, Chem. Res. Toxicol. 23 (2009) 319 (

A. Fonseca-Nunes, P. Jakszyn, A. Agudo, J. Cancer Epidemiol. Prev. 23 (2014) 12 (

S. Ohnishi, M. Murata, N. Ida, S. Oikawa, S. Kawanishi, Free Radical Res. 49 (2015) 1165 (

N. Somchit, S. Hassim, S. Samsudin, Hum. Exp. Toxicol. 21 (2002) 43 (

D. Yüzbaşıoğlu, F. Ünal, S. Yılmaz, H. Aksoy, M. Celik, Mutat. Res. Genet. Toxicol. Environ. Mutagen. 649 (2008) 155 (

R. M. d. S. Correa, T. C. Mota, A. C. Guimarães, L. T. Bonfim, R. R. Burbano, M. d. O. Bahia, Biomed. Res. Int. 2018 (2018) 1 (

G. Silva, L. Zuravski, M. Duarte, M. Machado, L. Oliveira, Immunopharmacol. Immunotoxicol. 41 (2019) 123 (

X.-Y. Meng, H.-X. Zhang, M. Mezei, M. Cui, Curr. Comput. Aided Drug Des. 7 (2011) 146 (

I. Ul-Haq, N. Ullah, G. Bibi, S. Kanwal, M. S. Ahmad, B. Mirza, Iran J. Pharm. Res. 11 (2012) 241 (

B. Coban, U. Yildiz, Appl. Biochem. Biotechnol. 172 (2014) 248 (

RCSB PDB,, (2020)

PubChem,, (2020)

Accelrys Software Inc. San Diego,, (2011)

O. Trott, A. J. Olson, J. Comput. Chem. 31 (2010) 455 (

A. C. Wallace, R. A. Laskowski, J. M. Thornton, Protein. Eng. Des. Sel. 8 (1995) 127 (

R. G. Moreno, M. V. Alipázaga, O. F. Gomes, E. Linares, M. H. Medeiros, N. Coichev, J. Inorg. Biochem. 101 (2007) 866 (

M. Kami, Y. Sawada, S. i. Mori, J. Hirate, N. Kojima, Y. Kanda, A. Moriya, K. Yuji, T. Saito, S. Chiba, Am. J. Hematol. 66 (2001) 85 (;2-M)

S. J. Padayatty, M. Levine, Oral Dis. 22 (2016) 463 (

N. Cavarocchi, M. England, H. V. Schaff, P. Russo, T. Orszulak, J. W. Schnell, J. O'Brien, J. Pluth, Circulation 74 (1986) 130 (

Y. Yamamoto, M. H. Brodsky, J. C. Baker, B. N. Ames, Anal. Biochem. 160 (1987) 7 (

C. Salustri, R. Squitti, F. Zappasodi, M. Ventriglia, M. G. Bevacqua, M. Fontana, F. Tecchio, J. Affect. Disord. 127 (2010) 321 (

G. McAuley, M. Schrag, S. Barnes, A. Obenaus, A. Dickson, B. Holshouser, W. Kirsch, Mgn. Reson. Med. 65 (2011) 1592 (

Y. Li, Y. Zheng, Y. Zhang, J. Xu, G. Gao, Molecules 23 (2018) 1 (

M. C. Linder, Mutat. Res. 733 (2012) 83 (

C. Garcia, Master of Science Thesis, Clemson University, 2011 (

D. Bar-Or, G. W. Thomas, L. T. Rael, E. P. Lau, J. V. Winkler, Biochem. Biophys. Res. Commun. 282 (2001) 356 (

K. Yokawa, T. Kagenishi, T. Kawano, Biosci. Biotechnol. Biochem. 75 (2011) 1377 (

C. A. Peng, A. A. Gaertner, S. A. Henriquez, D. Fang, R. J. Colon-Reyes, J. L. Brumaghim, L. Kozubowski, PLoS One 13 (2018) 1 (

R. Valipour, M. B. Yilmaz, E. Valipour, Drug Res. 69 (2019) 545 (

C.-Y. Zhou, X.-L. Xi, P. Yang, Biokhimiia 72 (2007) 37 (

J. M. Gottesfeld, J. M. Turner, P. B. Dervan, Gene Expr. 9 (2001) 77 (

S. A. Shaikh, S. R. Ahmed, B. Jayaram, Arch. Biochem. Biophys. 429 (2004) 81 (


Copyright (c) 2020 Journal of the Serbian Chemical Society

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

5 Year Impact Factor 1.023
138 of 177 journals)